Differences in BMI between Mexican and Colombian patients receiving antipsychotics

results from the International Study of Latinos on Antipsychotics (ISLA)

Bernardo Ng, Alvaro Camacho, Katherine Parra, Ricardo de la Espriella, Victor Rico, Severiano Lozano, Mirna Troncoso, Ruby C. Castilla-Puentes, Benjamin L. Cook, Daniel Enrique Jimenez

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective: The objective of this study is to examine the association of country of residence with body mass index (BMI) between Mexican and Colombian patients exposed to antipsychotics. We hypothesize that there will be a significant association between country of residence and BMI and that Mexican patients will have higher BMI than their Colombian counterparts. Design: The International Study of Latinos on Antipsychotics (ISLA) is a multisite, international, cross sectional study of adult Latino patients exposed to antipsychotics in two Latin American Countries (i.e. Mexico and Colombia). Data were collected from a total of 205 patients (149 from Mexico and 56 from Colombia). The sites in Mexico included outpatient clinics in Mexicali, Monterrey and Tijuana. In Colombia, data were collected from outpatient clinics in Bogotá. For this study we included patients attending outpatient psychiatric community clinics that received at least one antipsychotic (new and old generation) for the last 3 months. A linear regression model was used to determine the association of country of residence with BMI for participants exposed to an antipsychotic. Results: After controlling for demographics, behaviors, biological and comorbid psychiatric variables, there was a significant difference between Colombia vs. Mexico in the BMI of patients exposed to antipsychotics (β = 4.9; p < 0.05). Conclusion: Our hypotheses were supported. These results suggest that differences in BMI in patients exposed to antipsychotics in Mexico and Colombia may reflect differences in prevalence of overweight/obesity at the population level in the respective countries, and highlights the involvement of other risk factors, which may include genetics.

Original languageEnglish (US)
Pages (from-to)1-8
Number of pages8
JournalEthnicity and Health
DOIs
StateAccepted/In press - Mar 9 2018

Fingerprint

Hispanic Americans
Antipsychotic Agents
Colombia
Body Mass Index
Mexico
outpatient clinic
Ambulatory Care Facilities
Linear Models
Biological Psychiatry
demographic situation
cross-sectional study
Latinos
Psychiatry
Outpatients
Obesity
Cross-Sectional Studies
regression
Demography
community
Population

Keywords

  • antipsychotics
  • cardiometabolic risk
  • Latino
  • obesity

ASJC Scopus subject areas

  • Cultural Studies
  • Arts and Humanities (miscellaneous)
  • Public Health, Environmental and Occupational Health

Cite this

Differences in BMI between Mexican and Colombian patients receiving antipsychotics : results from the International Study of Latinos on Antipsychotics (ISLA). / Ng, Bernardo; Camacho, Alvaro; Parra, Katherine; de la Espriella, Ricardo; Rico, Victor; Lozano, Severiano; Troncoso, Mirna; Castilla-Puentes, Ruby C.; Cook, Benjamin L.; Jimenez, Daniel Enrique.

In: Ethnicity and Health, 09.03.2018, p. 1-8.

Research output: Contribution to journalArticle

Ng, Bernardo ; Camacho, Alvaro ; Parra, Katherine ; de la Espriella, Ricardo ; Rico, Victor ; Lozano, Severiano ; Troncoso, Mirna ; Castilla-Puentes, Ruby C. ; Cook, Benjamin L. ; Jimenez, Daniel Enrique. / Differences in BMI between Mexican and Colombian patients receiving antipsychotics : results from the International Study of Latinos on Antipsychotics (ISLA). In: Ethnicity and Health. 2018 ; pp. 1-8.
@article{d3fb8b3b55764f9b9af3bd3b0c2292c6,
title = "Differences in BMI between Mexican and Colombian patients receiving antipsychotics: results from the International Study of Latinos on Antipsychotics (ISLA)",
abstract = "Objective: The objective of this study is to examine the association of country of residence with body mass index (BMI) between Mexican and Colombian patients exposed to antipsychotics. We hypothesize that there will be a significant association between country of residence and BMI and that Mexican patients will have higher BMI than their Colombian counterparts. Design: The International Study of Latinos on Antipsychotics (ISLA) is a multisite, international, cross sectional study of adult Latino patients exposed to antipsychotics in two Latin American Countries (i.e. Mexico and Colombia). Data were collected from a total of 205 patients (149 from Mexico and 56 from Colombia). The sites in Mexico included outpatient clinics in Mexicali, Monterrey and Tijuana. In Colombia, data were collected from outpatient clinics in Bogot{\'a}. For this study we included patients attending outpatient psychiatric community clinics that received at least one antipsychotic (new and old generation) for the last 3 months. A linear regression model was used to determine the association of country of residence with BMI for participants exposed to an antipsychotic. Results: After controlling for demographics, behaviors, biological and comorbid psychiatric variables, there was a significant difference between Colombia vs. Mexico in the BMI of patients exposed to antipsychotics (β = 4.9; p < 0.05). Conclusion: Our hypotheses were supported. These results suggest that differences in BMI in patients exposed to antipsychotics in Mexico and Colombia may reflect differences in prevalence of overweight/obesity at the population level in the respective countries, and highlights the involvement of other risk factors, which may include genetics.",
keywords = "antipsychotics, cardiometabolic risk, Latino, obesity",
author = "Bernardo Ng and Alvaro Camacho and Katherine Parra and {de la Espriella}, Ricardo and Victor Rico and Severiano Lozano and Mirna Troncoso and Castilla-Puentes, {Ruby C.} and Cook, {Benjamin L.} and Jimenez, {Daniel Enrique}",
year = "2018",
month = "3",
day = "9",
doi = "10.1080/13557858.2018.1439894",
language = "English (US)",
pages = "1--8",
journal = "Ethnicity and Health",
issn = "1355-7858",
publisher = "Routledge",

}

TY - JOUR

T1 - Differences in BMI between Mexican and Colombian patients receiving antipsychotics

T2 - results from the International Study of Latinos on Antipsychotics (ISLA)

AU - Ng, Bernardo

AU - Camacho, Alvaro

AU - Parra, Katherine

AU - de la Espriella, Ricardo

AU - Rico, Victor

AU - Lozano, Severiano

AU - Troncoso, Mirna

AU - Castilla-Puentes, Ruby C.

AU - Cook, Benjamin L.

AU - Jimenez, Daniel Enrique

PY - 2018/3/9

Y1 - 2018/3/9

N2 - Objective: The objective of this study is to examine the association of country of residence with body mass index (BMI) between Mexican and Colombian patients exposed to antipsychotics. We hypothesize that there will be a significant association between country of residence and BMI and that Mexican patients will have higher BMI than their Colombian counterparts. Design: The International Study of Latinos on Antipsychotics (ISLA) is a multisite, international, cross sectional study of adult Latino patients exposed to antipsychotics in two Latin American Countries (i.e. Mexico and Colombia). Data were collected from a total of 205 patients (149 from Mexico and 56 from Colombia). The sites in Mexico included outpatient clinics in Mexicali, Monterrey and Tijuana. In Colombia, data were collected from outpatient clinics in Bogotá. For this study we included patients attending outpatient psychiatric community clinics that received at least one antipsychotic (new and old generation) for the last 3 months. A linear regression model was used to determine the association of country of residence with BMI for participants exposed to an antipsychotic. Results: After controlling for demographics, behaviors, biological and comorbid psychiatric variables, there was a significant difference between Colombia vs. Mexico in the BMI of patients exposed to antipsychotics (β = 4.9; p < 0.05). Conclusion: Our hypotheses were supported. These results suggest that differences in BMI in patients exposed to antipsychotics in Mexico and Colombia may reflect differences in prevalence of overweight/obesity at the population level in the respective countries, and highlights the involvement of other risk factors, which may include genetics.

AB - Objective: The objective of this study is to examine the association of country of residence with body mass index (BMI) between Mexican and Colombian patients exposed to antipsychotics. We hypothesize that there will be a significant association between country of residence and BMI and that Mexican patients will have higher BMI than their Colombian counterparts. Design: The International Study of Latinos on Antipsychotics (ISLA) is a multisite, international, cross sectional study of adult Latino patients exposed to antipsychotics in two Latin American Countries (i.e. Mexico and Colombia). Data were collected from a total of 205 patients (149 from Mexico and 56 from Colombia). The sites in Mexico included outpatient clinics in Mexicali, Monterrey and Tijuana. In Colombia, data were collected from outpatient clinics in Bogotá. For this study we included patients attending outpatient psychiatric community clinics that received at least one antipsychotic (new and old generation) for the last 3 months. A linear regression model was used to determine the association of country of residence with BMI for participants exposed to an antipsychotic. Results: After controlling for demographics, behaviors, biological and comorbid psychiatric variables, there was a significant difference between Colombia vs. Mexico in the BMI of patients exposed to antipsychotics (β = 4.9; p < 0.05). Conclusion: Our hypotheses were supported. These results suggest that differences in BMI in patients exposed to antipsychotics in Mexico and Colombia may reflect differences in prevalence of overweight/obesity at the population level in the respective countries, and highlights the involvement of other risk factors, which may include genetics.

KW - antipsychotics

KW - cardiometabolic risk

KW - Latino

KW - obesity

UR - http://www.scopus.com/inward/record.url?scp=85043319075&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043319075&partnerID=8YFLogxK

U2 - 10.1080/13557858.2018.1439894

DO - 10.1080/13557858.2018.1439894

M3 - Article

SP - 1

EP - 8

JO - Ethnicity and Health

JF - Ethnicity and Health

SN - 1355-7858

ER -